No on Prop. 14; no need to replicate California's disappointing stem cell experiment
By Editorial Board,
San Francisco Chronicle
| 09. 24. 2020
Like MySpace, the Martha Stewart prosecution and American democratic norms, spending gobs of state money on stem cell research might sound like an artifact of the Aughts. And yet 16 years after voters agreed to borrow $3 billion to explore a promising new area of medical research, stem cells are back on the California ballot.
The state’s voters passed Proposition 71, which created the California Institute for Regenerative Medicine, in a fit of hope that stem cells could treat an array of diseases and injuries. President George W. Bush’s order limiting federally funded embryonic stem cell research on religious grounds added urgency and politics to the cause. Celebrities such as Michael J. Fox and Christopher Reeve urged Californians to step into the breach for them and countless others with incurable, often heart-rending conditions.
Now the Oakland-based agency’s backers want voters to approve an additional $5.5 billion under Proposition 14 to sustain not just a limitless possibility but also the more mundane and complex reality of the institute’s experience. Especially in a field as nascent as stem cells, science is slow...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...